ReleaseWire Connect

According to the U.S. Food and Drug Administration, Drug Device Combination Products are defined as therapeutic products comprising an active pharmaceutical ingredient and a medical device that are physically and/or chemically, combined to be produced as a single product. The drug present in the device may be impregnated or surface coated. Such products can be designed for local as well as systemic administration of drug to the patient. Recently, combination products are emerging as innovative medical products due to their contribution in advancing medical care and are thus expected to have major impact in the coming years.

Renewable chemicals are used for enhancing the use of renewable resources rather than fossil fuels. Renewable chemicals include all the chemicals which are produced from renewable feedstock such as microorganisms, biomass (plant, animal, and marine), and agricultural raw materials. Strict government regulations, environmental concerns and awareness among people are enhancing the use of bio-based products produced from biomass sources, which in turn is expanding the market for renewable chemicals.

Moldable semi-synthetic or synthetic organic solids are known as plastics. Plastic packaging revolutionized the packaging market by reducing the overall cost of packaging. Plastics are insoluble in water and chemically inert, due to which they are less toxic in nature. The traditional methods of packaging involved wood, paper etc. which incurred huge costs that was coupled with razing of forests. This ultimately led to the rise in global temperature and significant change in the climatic conditions across the globe.

Phosphoric fertilizers are manufactured by adding acid to ground or pulverized phosphate rock. Phosphate (SSP) is produced by employing sulfuric acid to chemically extract phosphate from phosphate rock. Organic phosphorus fertilizer has also been discovered in animal remains or in composted animal manure .Unrefined rock phosphate is also used as organic fertilizer, but it can take a number of years by plants to split it down enough for plants to access the nutrients.

Orthopedic biomaterials are organic or synthetic materials of biologic composition used for internal fixation of fracture. Biomaterial devices which are manufactured for large number of orthopedic applications are commonly termed as ‘Implants’. These biomaterials help in re-establishing the structural integrity of the damaged bone due to trauma or diseased conditions. Biocompatibility of the material is the primary factor to be considered before its usage in orthopedic applications. Other characteristics on which the success of biomaterials in biological applications depends on the choice of material for its construction, appropriate design, stability and various properties like hardness and tensile strength and their interaction with soft and hard tissues and intra and extracellular fluids of the human body and blood.

Hydrogen Peroxide is the simplest and versatile peroxide formed due to a chemical reaction between hydrogen and oxygen. It is a liquid, which is more viscous than water and is colorless in the diluted form. It is generally used as a chemical disinfectant. In addition, hydrogen peroxide is a strong oxidizing agent. It is naturally produced in human body which helps increasing immunity. It is used in a variety of medical and personal applications such as bleaching, sterilization, sanitizer, toothpastes, mouthwashes and hair color among others.

Transparency Market Research is Published new Market Report “Orthopedic Devices Market(Hip, Knee, Spine, Shoulder, Elbow, Foot and Ankle, Craniomaxillofacial and Other Extremities) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global orthopedic devices market was valued at USD 29.2 billion in 2012 and is expected to grow at a CAGR of 4.9% from 2013 to 2019, to reach an estimated value of USD 41.2 billion in 2019.

Telemedicine makes healthcare more interactive by utilizing latest technology and telecommunication. Telemedicine market is witnessing double digit growth in the past and will continue to do so in the future. Major factors driving telemedicine market is the increase in remote monitoring of patients along with the increasing demand for telesurgery. Global Telemedicine market is dominated by United States.

According to a new market report published by Transparency Market Research "Global Lithium Ion Battery Market (Cathode, Anode, and Electrolytic solution) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013- 2019", the global market was worth USD 11.70 billion in 2012 and is expected to reach USD 33.11 billion in 2019, growing at a CAGR of 14.4% from 2013 to 2019. Due to the increasing demand and huge potential of lithium-ion battery in consumer, automotive and industrial sectors, Asia Pacific was the largest market for lithium-ion batteries in 2012.

Biometrics refers to the technology utilized through measurement of physiological and behavioral characteristics used to identify computer users. Such physiological characteristics commonly include the face, fingerprints, and DNA. Behavioral characteristics commonly include the user’s digital signature, his or her voiceprint, and walk.